why choose us

First received: February 23, 2023

Clinical Trial: Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Study Status: Completed

Recruit Status: RECRUITING

Condition: IC-MPGN

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune Complex Mediated Membranoproliferative

Brief Summary: This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis.

Read more